Abstract
The neuropsychological symptoms associated with chemotherapy treatment remain a major challenge with their prevention hampered by insufficient understanding of pathophysiology. While long-term neuroimmune changes have been identified as a hallmark feature shared by neurological symptoms, the exact timeline of mechanistic events preceding neuroinflammation, and the relationship between the glial cells driving this neuroinflammatory response, remain unclear. We therefore aimed to longitudinally characterize the neuroimmunological changes following systemic 5-fluorouracil (5-FU) treatment to gain insight into the timeline of events preceding the well-documented chronic neuroinflammation seen following chemotherapy. Eighteen female C57Bl/6 mice received a single intraperitoneal dose of 5-FU and groups were killed at days 1 and 2 (acute timepoint), days 4 and 8 (subacute timepoint), and days 16 and 32 (chronic timepoint). A further six mice were administered with vehicle control with tissues collected from three mice on day 1 and day 32 of the study. The expression of key genes of interest, BCL2, BDNF, TIMP1, MMP-9, MMP-2, TNFα, IL-1β, and IL-6R were assessed using real time polymerase chain reaction. Levels of neurogenesis were determined through immunofluorescent staining of doublecortin (DCX). The density of microglia and astrocytes were assessed using immunofluorescence staining of Iba1 and GFAP respectively. 5-FU treatment caused significant decreases to DCX staining at acute timepoints (p = 0.0030) which was positively correlated with BCL2 expression levels. An increase to microglial density was observed in the prefrontal cortex (p = 0.0256), CA3 region (p = 0.0283), and dentate gyrus (p = 0.0052) of the hippocampus at acute timepoints. 5-FU caused increases to astrocyte density, across multiple brains regions, at subacute and chronic timepoints which were positively correlated with TNFα, TIMP-1, MMP-2, and IL-6R expression. This study has identified acute objective neuroinflammatory changes suggesting that the role of early intervention should be explored to prevent the development of neuropsychological deficits in the longer-term following chemotherapy.
Similar content being viewed by others
Data Availability
The datasets generated within this study are not currently available to the public. However, can be made available upon request to the corresponding author.
References
Nurgali K, Jagoe RT, Abalo R (2018) Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae? Front Pharmacol 9:245
Apple AC et al (2017) Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. Neuroimage Clin 14:685–691
Apple AC et al (2018) Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy. Neuroimage Clin 20:110–118
Kesler SR, Kent JS, O’Hara R (2011) Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68(11):1447–1453
Yang Y et al (2017) The relationship between cancer patient’s fear of recurrence and chemotherapy: a systematic review and meta-analysis. J Psychosom Res 98:55–63
Souza R et al (2020) Factors associated with sleep quality during chemotherapy: an integrative review. Nurs Open 7(5):1274–1284
Selamat MH et al (2014) Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS ONE 9(9):e108002
Ramsey I et al (2021) A core set of patient-reported outcomes for population-based cancer survivorship research: a consensus study. J Cancer Surviv 15(2):201–212
Huang J et al (2016) Symptom clusters in ovarian cancer patients with chemotherapy after surgery: a longitudinal survey. Cancer Nurs 39(2):106–116
Sullivan CW et al (2018) Stability of symptom clusters in patients with breast cancer receiving chemotherapy. J Pain Symptom Manage 55(1):39–55
Santos JC, Pyter LM (2018) Neuroimmunology of behavioral comorbidities associated with cancer and cancer treatments. Front Immunol 9:1195
Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98
Michopoulos V et al (2017) Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 42(1):254–270
Troubat R et al (2021) Neuroinflammation and depression: a review. Eur J Neurosci 53(1):151–171
Stephenson J et al (2018) Inflammation in CNS neurodegenerative diseases. Immunology 154(2):204–219
George RP et al (2021) Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: a systematic scoping review. Brain Behav Immun 94:392–409
Subramaniam CB et al (2020) The microbiota-gut-brain axis: an emerging therapeutic target in chemotherapy-induced cognitive impairment. Neurosci Biobehav Rev 116:470–479
Bowen J et al (2019) The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer 27(10):4023–4033
Wardill HR et al (2016) Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms. Mol Cancer Ther 15(6):1376–1386
Sritawan N et al (2020) Metformin alleviates memory and hippocampal neurogenesis decline induced by methotrexate chemotherapy in a rat model. Biomed Pharmacother 131:110651
Egeland M et al (2017) Depletion of adult neurogenesis using the chemotherapy drug temozolomide in mice induces behavioural and biological changes relevant to depression. Transl Psychiatry 7(4):e1101
Jiang ZG et al (2018) PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats. PLoS ONE 13(1):e0191866
Dioli C et al (2019) Chronic stress triggers divergent dendritic alterations in immature neurons of the adult hippocampus, depending on their ultimate terminal fields. Transl Psychiatry 9(1):143
Chesnokova V, Pechnick RN, Wawrowsky K (2016) Chronic peripheral inflammation, hippocampal neurogenesis, and behavior. Brain Behav Immun 58:1–8
Roxburgh CS, McMillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 110(6):1409–1412
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
Jung YJ et al (2019) Neuroinflammation as a factor of neurodegenerative disease: thalidomide analogs as treatments. Front Cell Dev Biol 7:313
Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254–1266
Rose-John S (2012) IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 8(9):1237–1247
Zhang R et al (2006) Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiol Dis 24(2):345–356
Numakawa T, Odaka H, Adachi N (2017) Actions of brain-derived neurotrophic factor and glucocorticoid stress in neurogenesis. Int J Mol Sci 18(11):2312. https://doi.org/10.3390/ijms18112312
Cătălin B et al (2013) Microglia: first responders in the central nervous system. Rom J Morphol Embryol 54(3):467–472
Pereira Dias G et al (2014) Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro Oncol 16(4):476–492
Gibson EM et al (2019) Methotrexate Chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment. Cell 176(1–2):43-55.e13
Formica V et al (2006) 5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma. Cancer Chemother Pharmacol 58(2):276–278
Shinde G et al (2020) Enhanced brain targeting efficiency using 5-FU (fluorouracil) lipid-drug conjugated nanoparticles in brain cancer therapy. Prog Biomater 9(4):259–275
Diasio RB, Harris BE (1989) Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16(4):215–237
Alexandrov T (2020) Spatial Metabolomics and imaging mass spectrometry in the age of artificial intelligence. Annu Rev Biomed Data Sci 3:61–87
Guzman-Martinez L et al (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10:1008
Wardill HR et al (2016) Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer 139(12):2635–2645
Perez-Dominguez M et al (2019) The detrimental effects of lipopolysaccharide-induced neuroinflammation on adult hippocampal neurogenesis depend on the duration of the pro-inflammatory response. Neural Regen Res 14(5):817–825
Zhao J et al (2019) Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep 9(1):5790
Welser-Alves JV, Crocker SJ, Milner R (2011) A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli. J Neuroinflammation 8:61
Könnecke H, Bechmann I (2013) The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas. Clin Dev Immunol 2013:914104
Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481–487
Runowicz CD et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43–73
Mandillo S et al (2008) Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genomics 34(3):243–255
Saré RM, Lemons A, Smith CB (2021) Behavior testing in rodents: highlighting potential confounds affecting variability and reproducibility. Brain Sci 11(4):522. https://doi.org/10.3390/brainsci11040522
Calcia MA et al (2016) Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 233(9):1637–1650
Acknowledgements
Ines Semendric for providing technical assistance. Adelaide Microscopy, University of Adelaide and Bioresources Staff, SAHMRI.
Funding
This work was supported by a Research Training Program Australia Stipend, The Doctor Chun Chung Wong and Madam So Sau Lam Memorial Postgraduate Cancer Research Top-Up Scholarship (CBS), and an NHMRC CJ Martin Biomedical Research Fellowship (HRW).
Author information
Authors and Affiliations
Contributions
Courtney Subramaniam: methodology, investigation, formal analysis, writing – original draft; Hannah Wardill: supervision, conceptualisation, formal analysis, writing – review & editing; Maya Davies: investigation; Vivien Heng: investigation; Marc Gladman: supervision, writing – review & editing; Joanne Bowen: supervision, conceptualization, writing – review & editing.
Corresponding author
Ethics declarations
Ethics Approval
The study was approved by the Animal Ethics Committee of the South Australian Health and Medical Research Institute (SAHMRI, #SAM20-034) and complied with the National Health and Research Council (Australia) Code of Practice for Animal Care in Research and Training (2014).
Consent to Participate
N/A.
Consent to Publish
N/A.
Competing Interests
Joanne Bowen has received research funding from AstraZeneca, Helsinn Healthcare, Pfizer Pharmaceuticals, PanTheryx, and Puma Biotechnology Inc. Hannah Wardill has received research funding from Nutricia (Danone) Research. Remaining authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Subramaniam, C.B., Wardill, H.R., Davies, M.R. et al. 5-Fluorouracil Induces an Acute Reduction in Neurogenesis and Persistent Neuroinflammation in a Mouse Model of the Neuropsychological Complications of Chemotherapy. Mol Neurobiol 60, 1408–1424 (2023). https://doi.org/10.1007/s12035-022-03136-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-022-03136-3